NVD Rates ThemeREX IPharm Object Injection Risk 9.8 in All Versions Through 1.2.4

The short version

• ThemeREX Group IPharm contains a critical deserialization flaw rated 9.8 by the NVD.
• Versions up to and including 1.2.4 are affected by this object injection vulnerability.
• No specific patch or remediation timeline is mentioned in the current NVD record.

The details

The National Vulnerability Database published CVE-2026-93936 regarding the ThemeREX Group IPharm plugin. The record identifies a "Deserialization of Untrusted Data" vulnerability, mapped to CWE-502. This weakness allows attackers to perform object injection by manipulating data that the plugin processes without sufficient validation. The flaw exists in the core handling of serialized objects, which can lead to unauthorized code execution if an attacker controls the input stream.

The NVD rating of 9.8 classifies this issue as critical. This high score reflects the ease of exploitation and the severe potential impact on the host system. The vulnerability affects the IPharm plugin specifically, which is part of the ThemeREX Group ecosystem. Developers using this plugin in their software stacks are exposed to this risk unless they verify the version and apply available mitigations.

The context

The vulnerability affects ThemeREX Group IPharm versions ranging from the initial release through version 1.2.4. The NVD record explicitly states that the issue is present in all versions "from n/a through 1.2.4." This means no version of the plugin prior to a potential future update is safe from this specific object injection vector.

ThemeREX Group is the vendor responsible for the IPharm plugin. The National Vulnerability Database serves as the primary source for this vulnerability classification. The record does not cite a specific third-party discovery date or a separate advisory from ThemeREX itself, relying on the standard CVE framework for disclosure.

What should you do?

• Audit your WordPress or CMS environment to check if IPharm version 1.2.4 or older is installed.
• Review server logs for unusual deserialization errors or unexpected object instantiation patterns.
• Restrict administrative access to the plugin settings to limit exposure to untrusted inputs.
• Monitor vendor communications for an official patch release that addresses CVE-2026-93936.

What to do and how to stay safe: ThemeREX Group

• Inventory all installed plugins and identify any running IPharm version 1.2.4 or earlier.
• Implement strict input validation on any endpoints that process serialized data from external sources.
• Enable detailed logging for PHP errors and deserialization warnings to detect exploitation attempts.
• Prepare a rollback plan in case an emergency update introduces instability into your production environment.

Step-by-step guide: Automatic Software Updates: 8 FAQs on Security and Risk

General security guidance from the DataSafe Times newsroom. It is not confirmed advice from the organisations named in this story.

Frequently asked questions

Which versions of ThemeREX IPharm are affected by CVE-2026-93936?

All versions of the IPharm plugin from its initial release through version 1.2.4 are affected.

What is the CVSS score for this vulnerability?

The National Vulnerability Database rates CVE-2026-93936 with a CVSS score of 9.8, which is critical.

What type of attack does this vulnerability allow?

The flaw allows for object injection through the deserialization of untrusted data, classified as CWE-502.